Scope of the Report:
This report studies the Aneurysmal Subarachnoid Hemorrhage market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Aneurysmal Subarachnoid Hemorrhage market by product type and applications/end industries.
Aneurysmal subarachnoid hemorrhage is a condition wherein a brain aneurysm ruptures, resulting in bleeding into the subarachnoid space.
The global Aneurysmal Subarachnoid Hemorrhage market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Aneurysmal Subarachnoid Hemorrhage.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Edge Therapeutics
Actelion Pharmaceuticals
Arbor Pharmaceuticals
Mayfield Brain & Spine
Europa Group
GE
Philips
Siemens
Trivitron
Toshiba
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Lumbar Puncture
Xanthochromia
Cerebral Angiography
Transcranial Doppler Ultrasound
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Aneurysmal Subarachnoid Hemorrhage Market Overview
1.1 Product Overview and Scope of Aneurysmal Subarachnoid Hemorrhage
1.2 Classification of Aneurysmal Subarachnoid Hemorrhage by Types
1.2.1 Global Aneurysmal Subarachnoid Hemorrhage Revenue Comparison by Types (2017-2023)
1.2.2 Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Types in 2017
1.2.3 Computed Tomography (CT) Scan
1.2.4 Magnetic Resonance Imaging (MRI)
1.2.5 Lumbar Puncture
1.2.6 Xanthochromia
1.2.7 Cerebral Angiography
1.2.8 Transcranial Doppler Ultrasound
1.3 Global Aneurysmal Subarachnoid Hemorrhage Market by Application
1.3.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Aneurysmal Subarachnoid Hemorrhage Market by Regions
1.4.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Aneurysmal Subarachnoid Hemorrhage Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Aneurysmal Subarachnoid Hemorrhage Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Aneurysmal Subarachnoid Hemorrhage Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Aneurysmal Subarachnoid Hemorrhage Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Aneurysmal Subarachnoid Hemorrhage Status and Prospect (2013-2023)
1.5 Global Market Size of Aneurysmal Subarachnoid Hemorrhage (2013-2023)
2 Manufacturers Profiles
2.1 Edge Therapeutics
2.1.1 Business Overview
2.1.2 Aneurysmal Subarachnoid Hemorrhage Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2016-2017)
2.2 Actelion Pharmaceuticals
2.2.1 Business Overview
2.2.2 Aneurysmal Subarachnoid Hemorrhage Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Actelion Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2016-2017)
2.3 Arbor Pharmaceuticals
2.3.1 Business Overview
2.3.2 Aneurysmal Subarachnoid Hemorrhage Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mayfield Brain & Spine
2.4.1 Business Overview
2.4.2 Aneurysmal Subarachnoid Hemorrhage Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mayfield Brain & Spine Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2016-2017)
2.5 Europa Group
2.5.1 Business Overview
2.5.2 Aneurysmal Subarachnoid Hemorrhage Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Europa Group Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2016-2017)
2.6 GE
2.6.1 Business Overview
2.6.2 Aneurysmal Subarachnoid Hemorrhage Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GE Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2016-2017)
2.7 Philips
2.7.1 Business Overview
2.7.2 Aneurysmal Subarachnoid Hemorrhage Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Philips Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2016-2017)
2.8 Siemens
2.8.1 Business Overview
2.8.2 Aneurysmal Subarachnoid Hemorrhage Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Siemens Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2016-2017)
2.9 Trivitron
2.9.1 Business Overview
2.9.2 Aneurysmal Subarachnoid Hemorrhage Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Trivitron Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2016-2017)
2.10 Toshiba
2.10.1 Business Overview
2.10.2 Aneurysmal Subarachnoid Hemorrhage Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Toshiba Aneurysmal Subarachnoid Hemorrhage Revenue, Gross Margin and Market Share (2016-2017)
3 Global Aneurysmal Subarachnoid Hemorrhage Market Competition, by Players
3.1 Global Aneurysmal Subarachnoid Hemorrhage Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Aneurysmal Subarachnoid Hemorrhage Players Market Share
3.2.2 Top 10 Aneurysmal Subarachnoid Hemorrhage Players Market Share
3.3 Market Competition Trend
4 Global Aneurysmal Subarachnoid Hemorrhage Market Size by Regions
4.1 Global Aneurysmal Subarachnoid Hemorrhage Revenue and Market Share by Regions
4.2 North America Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
4.3 Europe Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
4.5 South America Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
5 North America Aneurysmal Subarachnoid Hemorrhage Revenue by Countries
5.1 North America Aneurysmal Subarachnoid Hemorrhage Revenue by Countries (2013-2018)
5.2 USA Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
5.3 Canada Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
5.4 Mexico Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
6 Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Countries
6.1 Europe Aneurysmal Subarachnoid Hemorrhage Revenue by Countries (2013-2018)
6.2 Germany Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
6.3 UK Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
6.4 France Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
6.5 Russia Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
6.6 Italy Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Countries
7.1 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue by Countries (2013-2018)
7.2 China Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
7.3 Japan Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
7.4 Korea Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
7.5 India Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
8 South America Aneurysmal Subarachnoid Hemorrhage Revenue by Countries
8.1 South America Aneurysmal Subarachnoid Hemorrhage Revenue by Countries (2013-2018)
8.2 Brazil Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
8.3 Argentina Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
8.4 Colombia Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Aneurysmal Subarachnoid Hemorrhage by Countries
9.1 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Revenue by Countries (2013-2018)
9.2 Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
9.3 UAE Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
9.4 Egypt Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
9.5 Nigeria Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
9.6 South Africa Aneurysmal Subarachnoid Hemorrhage Revenue and Growth Rate (2013-2018)
10 Global Aneurysmal Subarachnoid Hemorrhage Market Segment by Type
10.1 Global Aneurysmal Subarachnoid Hemorrhage Revenue and Market Share by Type (2013-2018)
10.2 Global Aneurysmal Subarachnoid Hemorrhage Market Forecast by Type (2018-2023)
10.3 Computed Tomography (CT) Scan Revenue Growth Rate (2013-2023)
10.4 Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2013-2023)
10.5 Lumbar Puncture Revenue Growth Rate (2013-2023)
10.6 Xanthochromia Revenue Growth Rate (2013-2023)
10.7 Cerebral Angiography Revenue Growth Rate (2013-2023)
10.8 Transcranial Doppler Ultrasound Revenue Growth Rate (2013-2023)
11 Global Aneurysmal Subarachnoid Hemorrhage Market Segment by Application
11.1 Global Aneurysmal Subarachnoid Hemorrhage Revenue Market Share by Application (2013-2018)
11.2 Aneurysmal Subarachnoid Hemorrhage Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Aneurysmal Subarachnoid Hemorrhage Market Size Forecast (2018-2023)
12.1 Global Aneurysmal Subarachnoid Hemorrhage Market Size Forecast (2018-2023)
12.2 Global Aneurysmal Subarachnoid Hemorrhage Market Forecast by Regions (2018-2023)
12.3 North America Aneurysmal Subarachnoid Hemorrhage Revenue Market Forecast (2018-2023)
12.4 Europe Aneurysmal Subarachnoid Hemorrhage Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Aneurysmal Subarachnoid Hemorrhage Revenue Market Forecast (2018-2023)
12.6 South America Aneurysmal Subarachnoid Hemorrhage Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Aneurysmal Subarachnoid Hemorrhage Picture
Table Product Specifications of Aneurysmal Subarachnoid Hemorrhage
Table Global Aneurysmal Subarachnoid Hemorrhage and Rev